Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetically defined variants of toll-like receptors 3, 7 and 9 as phenotype and risk modifier factors for psoriasis.
Julià M, Consuegra-Fernández M, Guilabert A, Muñoz C, Esteve A, Armiger-Borràs N, Santiago F, Arias MT, Romaní J, Ferrándiz C, Carrascosa JM, Pedrosa E, Alsina-Gibert M, Lozano F, Mascaró-Galy JM. Julià M, et al. Among authors: santiago f. J Dermatol Sci. 2018 Mar;89(3):301-304. doi: 10.1016/j.jdermsci.2017.12.004. Epub 2017 Dec 19. J Dermatol Sci. 2018. PMID: 29290528 No abstract available.
Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.
Consuegra-Fernández M, Julià M, Martínez-Florensa M, Aranda F, Català C, Armiger-Borràs N, Arias MT, Santiago F, Guilabert A, Esteve A, Muñoz C, Ferrándiz C, Carrascosa JM, Pedrosa E, Romaní J, Alsina M, Mascaró-Galy JM, Lozano F. Consuegra-Fernández M, et al. Among authors: santiago f. Cell Mol Immunol. 2018 Oct;15(10):898-906. doi: 10.1038/cmi.2017.119. Epub 2017 Dec 11. Cell Mol Immunol. 2018. PMID: 29225340 Free PMC article.
Corrigendum to "Genetically defined variants of toll-like receptors 3, 7 and 9 as phenotype and risk modifier factors for psoriasis" [89 (March (3)) (2018) 301-304].
Julià M, Consuegra-Fernández M, Guilabert A, Muñoz C, Esteve A, Armiger-Borràs N, Santiago F, Arias MT, Romaní J, Ferrándiz C, Carrascosa JM, Pedrosa E, Alsina-Gibert M, Lozano F, Mascaró-Galy JM. Julià M, et al. Among authors: santiago f. J Dermatol Sci. 2018 Sep;91(3):342. doi: 10.1016/j.jdermsci.2018.03.013. Epub 2018 Apr 1. J Dermatol Sci. 2018. PMID: 29615327 No abstract available.
C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration.
Giralt L, Figueras-Roca M, Eguileor BL, Romero B, Zarranz-Ventura J, Alforja S, Santiago F, Bolaños J, Lozano F, Dotti-Boada M, Sala-Puigdollers A, Dura P, Izquierdo-Serra J, Valero O, Adan A, Fonollosa A, Molins B. Giralt L, et al. Among authors: santiago f. Front Immunol. 2024 Apr 3;15:1330913. doi: 10.3389/fimmu.2024.1330913. eCollection 2024. Front Immunol. 2024. PMID: 38633250 Free PMC article.
A new look at TFPI inhibition of factor X activation.
Santiago F, Kaur A, Bride S, Monroe D, Leiderman K, Sindi S. Santiago F, et al. PLoS Comput Biol. 2024 Nov 15;20(11):e1012509. doi: 10.1371/journal.pcbi.1012509. eCollection 2024 Nov. PLoS Comput Biol. 2024. PMID: 39546494 Free PMC article.
292 results